1953
DOI: 10.1177/003591575304601218
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic Hypercalciuria (A Preliminary Report)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
45
0
11

Year Published

1971
1971
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(57 citation statements)
references
References 2 publications
1
45
0
11
Order By: Relevance
“…However, regardless of low urine volume, hypercalciuria was more common than other evaluated metabolic disorder in our study (17.81%). About 1% of patients with nephrolithiasis may suffer from primary hyperparathyroidism [9] while idiopathic hypercalciuria, which was described by Albright et al is the most common cause of hypercalciuria [10].…”
Section: Discussionmentioning
confidence: 99%
“…However, regardless of low urine volume, hypercalciuria was more common than other evaluated metabolic disorder in our study (17.81%). About 1% of patients with nephrolithiasis may suffer from primary hyperparathyroidism [9] while idiopathic hypercalciuria, which was described by Albright et al is the most common cause of hypercalciuria [10].…”
Section: Discussionmentioning
confidence: 99%
“…The term 'idiopathic hypercalciuria' (IH) was originally proposed by Albright et al [1] in 1953 to describe the association of elevated urinary calcium excretion with a normal serum calcium level in patients with calciumcontaining renal stones. Interest in the pathogenesis and management of IH has been sustained by the fact that it is one of the most-common metabolic abnormalities in humans and is present in approximately 60% of individuals with nephrolithiasis [2].…”
Section: Overview Of Idiopathic Hypercalciuriamentioning
confidence: 99%
“…Idiopathic hypercalciuria (IH) was first described by Albright et al [1], who defined it as an excessive urinary calcium loss accompanied by normal serum calcium levels. IH is the most common metabolic abnormality in patients with nephrolithiasis, accounting for 30-50% of calciumoxalate stone formers [2][3][4].…”
Section: Introductionmentioning
confidence: 99%